Close Menu

Nanoparticles can make clotting more effective, say researchers in Technology Review. Case Western University's Erin Lavik says that these particles, which attach themselves to the endogenous platelets, help clotting occur. In rodents with femoral artery injuries, the particles were able to cut bleeding time in half. Some day, the researchers say, this could be used to treat traumatic injuries, including those sustained by soldiers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.